Chloe Reavill

Chloe Reavill is a graduate student in the Ohio State Biochemistry Program at The Ohio State University, starting in August 2024. Previously, Chloe worked as a Research Associate at DTx Pharma, a Novartis Company, from May 2023 to July 2024, where responsibilities included designing in vitro and in vivo experiments for drug candidate characterization related to amyotrophic lateral sclerosis and spinocerebellar ataxia, processing mouse tissue samples, and developing an RT-qPCR assay. Prior to this role, Chloe held a position as Research Associate I at Sorrento Therapeutics, Inc. from July 2022 to March 2023, focusing on the development of mRNA constructs for HIV and COVID-19 variants for immunogenicity testing. Chloe also gained undergraduate research experience at UC Santa Barbara from March 2021 to September 2022, working in various biochemistry labs on projects involving enzyme studies and protein analysis while completing a Bachelor of Science in Biochemistry from September 2018 to June 2022.